Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. (KOSDAQ:A217330) from Jeon Byung Hee and others for KRW 110 billion on December 19, 2023. Transaction is financed through it's own funds.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,380 KRW | -3.70% | -6.57% | -30.62% |
1st Jan change | Capi. | |
---|---|---|
-30.62% | 153M | |
+3.25% | 3.43B | |
-0.37% | 2.27B | |
-19.19% | 2.03B | |
-22.57% | 1.63B | |
+32.82% | 1.16B | |
+14.12% | 714M | |
-8.30% | 703M | |
-31.22% | 500M | |
-4.97% | 279M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion